237 related articles for article (PubMed ID: 30603728)
1. Approach to wild-type gastrointestinal stromal tumors.
Kays JK; Sohn JD; Kim BJ; Goze K; Koniaris LG
Transl Gastroenterol Hepatol; 2018; 3():92. PubMed ID: 30603728
[TBL] [Abstract][Full Text] [Related]
2. [Wild-type gastroinestinal stromal tumors].
Djerouni M; Dumont SN
Bull Cancer; 2020 Apr; 107(4):499-505. PubMed ID: 32063345
[TBL] [Abstract][Full Text] [Related]
3. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
[TBL] [Abstract][Full Text] [Related]
4. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
[TBL] [Abstract][Full Text] [Related]
6. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
[TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs].
Kalfusová A; Kodet R
Cesk Patol; 2017; 53(4):167-173. PubMed ID: 29227120
[TBL] [Abstract][Full Text] [Related]
8. Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.
Belinsky MG; Cai KQ; Zhou Y; Luo B; Pei J; Rink L; von Mehren M
BMC Cancer; 2017 Aug; 17(1):512. PubMed ID: 28768491
[TBL] [Abstract][Full Text] [Related]
9. Biology of gastrointestinal stromal tumors.
Corless CL; Fletcher JA; Heinrich MC
J Clin Oncol; 2004 Sep; 22(18):3813-25. PubMed ID: 15365079
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
11. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
12. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).
Lasota J; Miettinen M
Semin Diagn Pathol; 2006 May; 23(2):91-102. PubMed ID: 17193822
[TBL] [Abstract][Full Text] [Related]
13. Pathology of gastrointestinal stromal tumors.
Hirota S; Isozaki K
Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
[TBL] [Abstract][Full Text] [Related]
14. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).
Nannini M; Biasco G; Astolfi A; Pantaleo MA
J Med Genet; 2013 Oct; 50(10):653-61. PubMed ID: 23833252
[TBL] [Abstract][Full Text] [Related]
15. Targeting Disease Persistence in Gastrointestinal Stromal Tumors.
Ordog T; Zörnig M; Hayashi Y
Stem Cells Transl Med; 2015 Jul; 4(7):702-7. PubMed ID: 25934947
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and pathogenesis of gastrointestinal stromal tumor.
Niinuma T; Suzuki H; Sugai T
Transl Gastroenterol Hepatol; 2018; 3():2. PubMed ID: 29441367
[TBL] [Abstract][Full Text] [Related]
17. Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents.
Ricci R; Martini M; Ravegnini G; Cenci T; Milione M; Lanza P; Pierconti F; Santini D; Angelini S; Biondi A; Rosa F; Alfieri S; Clemente G; Persiani R; Cassano A; Pantaleo MA; Larocca LM
Clin Epigenetics; 2019 Jan; 11(1):2. PubMed ID: 30616628
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal Stromal Tumors: The GIST of Precision Medicine.
Mei L; Smith SC; Faber AC; Trent J; Grossman SR; Stratakis CA; Boikos SA
Trends Cancer; 2018 Jan; 4(1):74-91. PubMed ID: 29413424
[TBL] [Abstract][Full Text] [Related]
19. Genetics of Gastrointestinal Stromal Tumors: A Heterogeneous Family of Tumors?
Patil DT; Rubin BP
Surg Pathol Clin; 2015 Sep; 8(3):515-24. PubMed ID: 26297068
[TBL] [Abstract][Full Text] [Related]
20. The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST).
Nannini M; Urbini M; Astolfi A; Biasco G; Pantaleo MA
J Transl Med; 2017 May; 15(1):113. PubMed ID: 28535771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
